Study on antiemetic drugs for chemotherapy-induced nausea and vomiting in oral cancer patients undergoing treatment with CDDP. I. Antiemetic efficacy of granisetron compared with metoclopramide.:—I. Antiemetic efficacy of granisetron compared with metoclo

概要

論文の詳細を見る
Nausea and vomiting induced by anticancer agents are common problems. In particular, cisplatin, the most popular anticancer agent against oral cancer, has severe nausea and vomiting. High-dose metoclopramide was used because its effect against cisplatin induced vomiting. However, it is not yet entirely effective. On the other hand, a novel antiemetic, 5-HT3 receptor antagonist is undergoing clinical evaluation. In this study, the efficacy and safety of granisetron were compared with those of high dose metoclopramide plus dexamethasone in patients undergoing treatment with cisplatin. The results were as follows: 1. Granisetron and high-dose metoclopramide are effective in preventing cisplatin-induced nausea and vomiting. 2. In the patients treated by granisetron compared with high-dose metoclopramide, the frequency of vomiting decreased, the appearance of nausea and vomiting were delayed, and the duration of nausea was shortened. 3. The effective rate of granisetron was 100% and that of high-dose metoclopramide 86.4% within 24 hours. 4. The side effects caused by granisetron were minimal. The above results revealed that granisetron showed an excellent antiemetic effect against acute chemotherapy-induced emesis within 24 hours compared with high-dose metoclopramide.
日本歯科薬物療法学会の論文